Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment

British Journal of Cancer

Volumn 98, Issue 11, 2008, Pages 1845-1851

  Badie, C ^a   Dziwura, S ^a   Raffy, C ^a   Tsigani, T ^a   Alsbeih, G ^b   Moody, J ^a   Finnon, P ^a   Levine, E ^c   Scott, D ^c   Bouffler, S ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Gene expression; Lymphocyte; Normal tissue response; QRT PCR (quantitative real time polymerase chain reaction); Radiation therapy; SNPs (single nucleotide polymorphisms)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PUMA PROTEIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOSENSITIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN MANIFESTATION;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RADIATION TOLERANCE; TRANSCRIPTION, GENETIC;

EID: 44349146591     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604381     Document Type: Article

References (45)

1. Alsbeih G, Al-Harbi N, Al-Buhairi M, Al-Hadyan K, Al-Hamed M (2007) Association between TP53 codon 72 single-nucleotide polymorphism and radiation sensitivity of human fibroblasts. Radiat Res 167: 535-540
2. Amundson SA, Grace MB, McLeland CB, Epperly MW, Yeager A, Zhan Q, Greenberger JS, Fornace Jr AJ (2004) Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 64: 6368-6371
3. Amundson SA, Lee RA, Koch-Paiz CA, Bittner ML, Meltzer P, Trent JM, Fornace Jr AJ (2003) Differential responses of stress genes to low doserate gamma irradiation. Mol Cancer Res 1: 445-452
4. Andreassen CN (2005) Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 44: 801-815
5. Andreassen CN, Alsner J, Overgaard M, Overgaard J (2003) Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69: 127-135
6. Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J, Warren C, Scott D (1997) Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76: 1546-1549
7. Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter AC (2000) Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. Mol Cell Biol 20: 2358-2366
8. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506
9. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677
10. Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D (2000) Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 55: 179-186
11. Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J, Peters LJ (1995) Fibroblast radiosensitivity vs acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 32: 1371-1379
12. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679
13. Chedid M, Michieli P, Lengel C, Huppi K, Givol D (1994) A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 9: 3021-3024
14. Cole J, Arlett CF (1994) Cloning efficiency and spontaneous mutant frequency in circulating T-lymphocytes in ataxia-telangiectasia patients. Int J Radiat Biol 66: S123-S131
15. Correa CR, Cheung VG (2004) Genetic variation in radiation-induced expression phenotypes. Am J Hum Genet 75: 885-890
16. Garman KS, Nevins JR, Potti A (2007) Genomic strategies for personalized cancer therapy. Hum Mol Genet 16(Spec No. 2): R226-R232
17. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA (1993) Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 27: 1173-1179
18. Grace MB, McLeland CB, Blakely WF (2002) Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. Int J Radiat Biol 78: 1011-1021
19. Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, Gostissa M, Dobbelstein M, Del Sal G, Piaggio G, Mantovani R (2005) Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 25: 3737-3751
20. Jen KY, Cheung VG (2003) Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 13: 2092-2100
21. Johansen J, Bentzen SM, Overgaard J, Overgaard M (1996) Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40: 101-109
22. Kruse JJ, Stewart FA (2007) Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response. World J Gastroenterol 13: 2669-2674
23. Lee JH, Paull TT (2005) ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308: 551-554
24. Li G, Liu Z, Sturgis EM, Shi Q, Chamberlain RM, Spitz MR, Wei Q (2005) Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 26: 1596-1602
25. Lopez E, Guerrero R, Nunez MI, del Moral R, Villalobos M, Martinez-Galan J, Valenzuela MT, Munoz-Gamez JA, Oliver FJ, Martin-Oliva D, Ruiz de Almodovar JM (2005) Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes. Breast Cancer Res 7: R690-R698
26. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, Cheung VG (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430: 743-747
27. Peacock J, Ashton A, Bliss J, Bush C, Eady J, Jackson C, Owen R, Regan J, Yarnold J (2000) Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol 55: 173-178
28. Pim D, Banks L (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108: 196-199
29. Rieger KE, Chu G (2004) Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Res 32: 4786-4803
30. Rieger KE, Hong WJ, Tusher VG, Tang J, Tibshirani R, Chu G (2004) Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci USA 101: 6635-6640
31. Rodningen OK, Borresen-Dale AL, Alsner J, Hastie T, Overgaard J (2007) Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol 86: 314-320
32. Russell NS, Grummels A, Hart AA, Smolders IJ, Borger J, Bartelink H, Begg AC (1998) Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. Int J Radiat Biol 73: 661-670
33. Smilenov LB, Brenner DJ, Hall EJ (2001) Modest increased sensitivity to radiation oncogenesis in ATM heterozygous vs wild-type mammalian cells. Cancer Res 61: 5710-5713
34. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG (2007) Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 39: 226-231
35. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, Franken NA, Haveman J, Klein B, Turesson I, Vrieling H, Giphart-Gassler M (2006) Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 3: e422
36. Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2006) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97: 255-262
37. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100
38. Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923
39. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121
40. Wang WD, Chen ZT, Li DZ, Cao ZH, Sun SL, Pu P, Chen XP (2005) Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients. Clin Cancer Res 11: 5140-5145
41. Wang YA, Elson A, Leder P (1997) Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci USA 94: 14590-14595
42. Watts JA, Morley M, Burdick JT, Fiori JL, Ewens WJ, Spielman RS, Cheung VG (2002) Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am J Hum Genet 71: 791-800
43. West CM, Davidson SE, Elyan SA, Valentine H, Roberts SA, Swindell R, Hunter RD (2001) Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 51: 10-15
44. Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A (2008) Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 47: 137-148
45. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100: 1931-1936